Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
side effects
Biotech
Merck stops phase 3 TIGIT trial in lung cancer for futility
The Big Pharma terminated a pivotal small cell lung cancer study after an interim review revealed efficacy and safety problems.
Nick Paul Taylor
Aug 8, 2024 7:49am
Monopar spikes chemo side effect drug after phase 2/3 analysis
Mar 28, 2023 11:33am
Novartis suspends dosing in phase 2b Huntington's disease trial
Aug 24, 2022 1:03pm
A fix to PI3K cancer drugs' immune toxicity?
May 4, 2022 11:00am
FDA approves Abbott's latest Amplatzer Talisman heart implant
Oct 4, 2021 9:50am
In vivo gene editing grabs the spotlight after Intellia triumph
Sep 29, 2021 3:00am
